Skip to content

Clinical trials

Phase 1/2 Carcinoma, Renal Cell trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 1/2 Country / region: Italy Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20031
20051
20151
20162
20191
20212
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated3
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center3
Bristol-Myers Squibb2
Consorzio Oncotech1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Genenta Science1
Kymab Limited1
Nektar Therapeutics1
Novartis Pharmaceuticals1
Philogen S.p.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell12
Carcinoma, Non-Small-Cell Lung4
Melanoma4
Hodgkin Disease3
Leukemia, Lymphocytic, Chronic, B-Cell3
Leukemia, Myeloid, Acute3
Leukemia, Myelomonocytic, Chronic3
Lymphoma, Non-Hodgkin3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Triple Negative Breast Neoplasms3

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.